FDA Adverse Event Malfunction Summary report: N

ID NOW COVID-19 ASSAY

MDR report key: 14429429 · Received May 18, 2022

Report

Report Number
1221359-2022-02294
Event Type
Malfunction
Date Received
May 18, 2022
Date of Event
April 27, 2022
Report Date
May 17, 2022
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QJR
UDI-DI
10811877011320
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: SIMILAR PRODUCT TO 190-000. INVESTIGATION SUMMARY: TESTING WAS PERFORMED IN DUPLICATE AT ABBOTT DIAGNOSTICS (B)(4), INC. ON RETAINED KIT LOT 1063244 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 191-000 / LOT 1063244 AND TEST BASE PART NUMBER 190-430 / LOT 1063244. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. THE CURRENT OVERALL INCIDENT RATE FOR FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) FOR THIS SPECIFIC LOT BASED ON THE TOTAL QUANTITY OF DEVICES DISTRIBUTED IS (B)(4). THE CURRENT OVERALL INCIDENT RATE FOR FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) FOR THIS SPECIFIC LOT BASED ON THE TOTAL QUANTITY OF DEVICES DISTRIBUTED IS (B)(4) BASED ON THE EVIDENCE AVAILABLE, THIS DEVICE LOT IS PERFORMING AS EXPECTED. IN CONCLUSION, THE RETENTION TESTING YIELDED EXPECTED RESULTS WHEN TESTING INTERNAL QC SAMPLES. THE MANUFACTURING BATCH RECORD REVIEW REVEALED THAT THE PRODUCT MET ACCEPTANCE CRITERIA FOR RELEASE. ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, A POSSIBLE ASSIGNABLE ROOT CAUSE IS PATIENT SAMPLE INTERFERENCE. SUBSTANCES IN THE SAMPLE ITSELF MAY HAVE INTERFERED WITH THE REACTION.

Description of Event or Problem · 0

THE CUSTOMER REPORTED CONFLICTING RESULTS WHEN TESTING A NASAL SWAB SAMPLE ON THE ID NOW COVID-19 ASSAY ON (B)(6) 2022. THE PATIENT'S FIRST SAMPLE GENERATED A POSITIVE RESULT. DUE TO THE POSITIVE RESULT, THE PATIENT WAS IMMEDIATELY RETESTED ON THE SAME ID NOW COVID-10 ASSAY USING A NEWLY COLLECTED NASAL SAMPLE WHICH GENERATED A NEGATIVE RESULT. THE PATIENT WAS REPORTED TO BE SYMPTOMATIC. NO FURTHER INFORMATION WAS PROVIDED REGARDING HEALTH STATUS AND OUTCOME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1502909 ID NOW COVID-19 ASSAY MOLECULAR IVD FOR ID NOW COVID-19 QJR ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 1063244 10811877011320

Patients

Seq Age Sex Outcome Treatment
1 Unknown